Martin Figeac

4.1k citations

81 papers · 1.6k indexed · h-index 25

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 17
- Acute Myeloid Leukemia Research 16
Cancer Research 18
- Cancer Genomics and Diagnostics 12

Co-authors: Céline Villenet Claude Preudhomme Frédéric Leprêtre Fabrice Jardin Aline Renneville Hervé Dombret Sandrine Geffroy Olivier Nibourel
Journals: Blood (8 papers)Scientific Reports (5 papers)Journal of Thoracic Oncology (4 papers)Frontiers in Immunology (3 papers)Leukemia Research (3 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Martin Figeac

77 papers receiving 1.6k citations

Peers

Countries citing papers authored by Martin Figeac

Since Specialization

Citations

This map shows the geographic impact of Martin Figeac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Figeac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Figeac more than expected).

Fields of papers citing papers by Martin Figeac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Figeac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Figeac. The network helps show where Martin Figeac may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin Figeac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Figeac Line = papers co-authored together Martin Figeac links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia British Journal of Haematology ·Seong Su Nah, Simone Santana Ferraz, Delphine Lebon, Justyna Stawarczyk, Véronique Harrivel, Elie Traer, 夏珩, Alice Marceau‐Renaut, Sandrine Geffroy, Li W, Hasse, Laurène Fenwarth, Céline Berthon, Jean‐Pierre Marolleau, Martin Figeac, Claude Preudhomme, Nicolas Duployez	2025	1
2	Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells RMD Open ·D. P. Silva, 韩会军, Fabrice Bray, 政一安江, Alain Lescoat, M McNelis, Martin Figeac, 厚子徳井, Frédéric Leprêtre, Sreekanth Kandikattu, É. Hachulla, Christian Rolando, Valérie Lecureur, Sylvain Dubucquoi, С.Г. Стародубцев, Vincent Sobanski	2025	3
3	Characteristics and impact of infiltration of B-cells from systemic sclerosis patients in a 3D healthy skin model Frontiers in Immunology ·Susan Frances Kuefler, Thomas Guerrier, Thiago de Castro Leite, Mehdi Derhourhi, Emeric Vuillemin, Hyeongki Lee, Amélie Bonnefond, Céline Villenet, Shéhérazade Sebda, Antonino Bongiovanni, Meryem Tardivel, A. Vallis, Manel Jendoubi, 庞天翔, Anja Jess‐Hempen, Martin Figeac, Sylvain Dubucquoi, David Launay	2024	3
4	Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France HemaSphere ·S. Trompert, Pierre Sujobert, Olivier Kosmider, Damien Luque Paz, Sophie Kaltenbach, Martin Figeac, Sandrine Hayette, Chao Huang, E. Kim, Hamada THABET, Audrey Bidet, Yannick Le Bris, Éric Delabesse, Frédéric Davi, Claude Preudhomme, Isabelle Durand‐Zaleski, Elizabeth Macintyre, (unknown)	2023	2
5	Gene/environment interaction in the susceptibility of Crohn's disease patients to aluminum The Science of The Total Environment ·Madjid Djouina, Christophe Waxin, Frédéric Leprêtre, Meryem Tardivel, Olivier Tillement, Francis Vasseur, Martin Figeac, Antonino Bongiovanni, Shéhérazade Sebda, Pierre Desreumaux, David Launay, Laurent Dubuquoy, Mathilde Body–Malapel, Cécile Vignal	2022	11
6	Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity PLoS ONE ·Hamdani Nurdin, Frédéric Leprêtre, Shéhérazade Sebda, Céline Villenet, Ramesh Kalam, Martin Figeac, Bruno Quesnel, Carine Brinster	2022	2
7	A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion Frontiers in Immunology ·Richards Rd, Domagoj Maričić, Frédéric Leprêtre, Martin Figeac, Thomas Guerrier, 宋奕青, 高奥, Gina Vieira Ponte de Albuquerque, Anneli Peters, Lennart T. Mars, Hélène Zéphir	2022	10
8	Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r BMC Bioinformatics ·Seong Su Nah, Yukana Kishima, Nicolas Duployez, Martin Figeac, Sandrine Geffroy, Maxime Bucci, Karine Celli‐Lebras, Matthieu Duchmann, 夏珩, Laurène Fenwarth, Olivier Nibourel, Simone Santana Ferraz, Raphaël Itzykson, Hervé Dombret, Mathilde Hunault, Claude Preudhomme, Mikaël Salson	2022	0
9	Simple gene signature to assess murine fibroblast polarization Scientific Reports ·K Lutnicki, Manel Jendoubi, Thiago de Castro Leite, Thomas Guerrier, Anja Jess‐Hempen, Silvia Speca, 韩会军, Fabrice Bray, Martin Figeac, É. Hachulla, Myriam Labalette, Frédéric Leprêtre, 清志松岡, Sébastien Sanges, Christian Rolando, Vincent Sobanski, Sylvain Dubucquoi, David Launay	2022	4
10	The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels Molecular Oncology ·裕之大西, Mohammad Ahmad, Pierre‐Marie Morice, Bernard Lambert, Louis‐Bastien Weiswald, Mégane Vernon, Nicolas Vigneron, Edwige Abeilard, Émilie Brotin, Martin Figeac, Pascal Gauduchon, Laurent Poulain, Christophe Denoyelle, Matthieu Meryet‐Figuière	2021	32
11	Galectin-3 modulates epithelial cell adaptation to stress at the ER-mitochondria interface Cell Death and Disease ·Lucie Coppin, Arnaud Jannin, Emilie Ait‐Yahya, C. Thuillier, Céline Villenet, Meryem Tardivel, Antonino Bongiovanni, Sen-Jen Lin, Simon de Beco, Nicolas Barois, Isabelle Van Seuningen, Emmanuelle Durand, Amélie Bonnefond, Zeghbib Samir, Jòseph Vamecq, Martin Figeac, Audrey Vincent, Delphine Delacour, Nicole Porchet, Pascal Pigny	2020	24
12	Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease Communications Biology ·Neşet Neşetoğlu, Ahmed Mahfouz, Angela Ingrassia, Jasmeet Ahuja, Céline Villenet, Eugénie Mutez, Thomas Comptdaer, Boudewijn P. F. Lelieveldt, Martin Figeac, Marie‐Christine Chartier‐Harlin, Wilma D. J. van de Berg, Jacobus J. van Hilten, Marcel Reinders	2020	51
13	s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells Stem Cell Reports ·Lü Tian, Marie‐José Truong, Chann Lagadec, Éric Adriaenssens, Emmanuel Bouchaert, Emina Sarajlić, Martin Figeac, Xuefen Le Bourhis, Roland P. Bourette	2019	6
14	Evolution of the human cold/menthol receptor, TRPM8 Molecular Phylogenetics and Evolution ·Samuel Blanquart, Anne‐Sophie Borowiec, Philippe Delcourt, Martin Figeac, Christopher A. Emerling, Andrea S. Meseguer, Morad Roudbaraki, Natalia Prevarskaya, Gabriel Bidaux	2019	17
15	High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study Journal of Thoracic Oncology ·Simon Baldacci, Martin Figeac, Martine Antoine, 高野優香, Zoulika Kherrouche, Philippe Jamme, Marie‐Christine Copin, David Tulasne, Isabelle Nanni, Michèle Beau‐Faller, Samia Melaabi, Guénaëlle Levallet, Élisabeth Quoix, Denis Moro‐Sibilot, S. Friard, Pascale Missy, Fabrice Barlési, Jacques Cadranel, Alexis B. Cortot	2019	16
16	DiNAMO: highly sensitive DNA motif discovery in high-throughput sequencing data BMC Bioinformatics ·Chadi Saad, Laurent Noé, Hugues Richard, Julie Leclerc, Marie‐Pierre Buisine, Hélène Touzet, Martin Figeac	2018	5
17	BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial Annals of Oncology ·Tony Petrella, Christiane Copie‐Bergman, Josette Brière, Richard Delarue, Fabrice Jardin, Philippe Ruminy, Catherine Thiéblemont, Martin Figeac, Danielle Canioni, Pierre Feugier, Bettina Fabiani, Karen Leroy, Marie Parrens, Marc André, Corinne Haïoun, Gilles Salles, Philippe Gaulard, Hervé Tilly, 藤本新平, Thierry Jo Molina	2017	14
18	Vaginal Mucosal Homeostatic Response May Determine Pregnancy Outcome in Women With Bacterial Vaginosis Medicine ·Emmanuel Faure, Karine Faure, Martin Figeac, Éric Kipnis, Teddy Grandjean, Sylvain Dubucquoi, Céline Villenet, Bruno Grandbastien, G. Brabant, D. Subtil, Rodrigue Dessein	2016	12
19	Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia Clinical Cancer Research ·Stéphanie Poulain, Christophe Roumier, Sondre Heggernes Padøy, Martin Figeac, Charles Herbaux, Guillemette Marot, Neiva Maria Batista Vieira, Elisabeth Bertrand, Sandrine Geffroy, Frédéric Leprêtre, Olivier Nibourel, محمد نصر الدين علام محمد نصر الدين علام, Eileen M. Boyle, Aline Renneville, Sabine Tricot, Agnès Daudignon, Bruno Quesnel, Patrick Duthilleul, Claude Preudhomme, Xavier Leleu	2015	82
20	Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients Leukemia Research ·Mohammed A. Al Balushi, Diane Wilkinson, Frédéric Leprêtre, Sélim Corm, Franck E. Nicolini, Christophe Roumier, Olivier Nibourel, Nathalie Grardel, Véronique Maguer‐Satta, Thierry Idziorek, Martin Figeac, Jean-Luc Laı̈, Bruno Quesnel, Gabriel Étienne, François Guilhot, Éric Lippert, Claude Preudhomme, Catherine Roche‐Lestienne	2010	10

About Martin Figeac

Martin Figeac is a scholar working on Hematology, Cancer Research, Genetics, Pathology and Forensic Medicine and Immunology, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Cancer Genomics and Diagnostics (12 papers), Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (8 papers), RNA modifications and cancer (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Hematology (362 citations), Genetics (259 citations), Pathology and Forensic Medicine (278 citations), Cancer Research (204 citations) and Immunology (257 citations). Martin Figeac has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Céline Villenet, Claude Preudhomme, Frédéric Leprêtre, Fabrice Jardin, Aline Renneville, Hervé Dombret, Sandrine Geffroy, Olivier Nibourel, Nicolas Duployez and Shéhérazade Sebda. Their work appears in journals such as Blood, Scientific Reports, Journal of Thoracic Oncology, Frontiers in Immunology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact